Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Mullan

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.
Cancer Research|November 17, 2005
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible geneRichard D Kennedy, Julia J Gorski, Jennifer E Quinn, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
Cell Communication and Signaling : CCS|September 26, 2024
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancersCharlotte Zoe Angel, Shannon Beattie, Ezanee Azlina Mohamad Hanif, et al.
Molecular Oncology|March 28, 2015
PICan: An integromics framework for dynamic cancer biomarker discoveryDarragh G McArt, Jaine K Blayney, David P Boyle, et al.
Gynecologic Oncology|September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinomaJames P Beirne, Darragh G McArt, Aideen Roddy, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Journal of the National Cancer Institute|November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancerAlison M Hosey, Julia J Gorski, Margaret M Murray, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.
Cancer Research|November 17, 2005
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible geneRichard D Kennedy, Julia J Gorski, Jennifer E Quinn, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
Cell Communication and Signaling : CCS|September 26, 2024
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancersCharlotte Zoe Angel, Shannon Beattie, Ezanee Azlina Mohamad Hanif, et al.
Molecular Oncology|March 28, 2015
PICan: An integromics framework for dynamic cancer biomarker discoveryDarragh G McArt, Jaine K Blayney, David P Boyle, et al.
Gynecologic Oncology|September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinomaJames P Beirne, Darragh G McArt, Aideen Roddy, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Journal of the National Cancer Institute|November 15, 2007
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancerAlison M Hosey, Julia J Gorski, Margaret M Murray, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Pageof 4